Quay Pharma, a contract development and manufacturing organization (CDMO), has been acquired by SGS, the Swiss-based (TIC) Testing, Inspection and Certification company.   The acquisition provides Quay with the investment to further grow its range of services and capabilities to support pharmaceutical clinical development, from pre-clinical to formulation, dosage form design and optimization, as well as clinical trial manufacture and supply.   In particular, it will enhance the development o...